AI Article Synopsis

  • The study aimed to analyze echocardiographic parameters in postmenopausal women with normocalcemic primary hyperparathyroidism (NCPHPT) compared to those with hypercalcemic primary hyperparathyroidism and healthy controls.
  • Results showed that women with hypercalcemic PHPT had significantly altered calcium and parathyroid hormone levels, while NCPHPT patients displayed higher phosphorus but similar cardiovascular risk factors and echocardiographic outcomes compared to controls.
  • The findings suggest no significant differences in heart health metrics among the groups, indicating that NCPHPT may not impact cardiovascular parameters as seen in patients with hypercalcemic PHPT.

Article Abstract

Objective: There are no data regarding echocardiographic parameters in patients with normocalcemic primary hyperparathyroidism (NCPHPT). We compared the echocardiographic findings in postmenopausal women with NCPHPT with those in patients with hypercalcemic primary hyperparathyroidism (PHPT) and controls.

Methods: Seventeen consecutive Caucasian postmenopausal women with NCPHPT were compared with 20 women with hypercalcemic PHPT and 20 controls. Obesity, diabetes, kidney failure, and previous cardiovascular diseases were considered exclusion criteria. Each patient underwent biochemical evaluation, bone mineral density scan, and echocardiographic measurements. Patients with parathyroid disorders underwent kidney ultrasound evaluation.

Results: Patients with PHPT had significantly higher mean total serum calcium, ionized calcium, 24-hour urinary calcium, and parathyroid hormone and lower mean phosphorus levels compared with those in the controls (all P < .05). The only differences between patients with NCPHPT and PHPT were significantly lower mean total serum calcium, ionized calcium, and 24-hour urinary calcium and higher phosphorus levels in patients with NCPHPT (all P < .05). The only biochemical difference between patients with NCPHPT and the controls was a higher level of mean parathyroid hormone in patients with NCPHPT. There were no differences in cardiovascular risk factors between patients with NCPHPT and PHPT and the controls. Hypertension was the most frequent cardiovascular risk factor, diagnosed in 65% of patients with PHPT. This high prevalence was not statistically significant compared with that observed in patients with NCPHPT (59%) and in the controls (30%). Echocardiography parameters were not different between patients with NCPHPT and PHPT and the controls when subdivided according to the presence of hypertension (ANOVA followed by Bonferroni correction).

Conclusion: In a population with a low cardiovascular risk, we found no differences in cardiovascular risk factors and echocardiographic parameters between patients with NCPHPT and PHPT and the controls.

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP-2020-0405DOI Listing

Publication Analysis

Top Keywords

patients ncphpt
32
phpt controls
16
ncphpt phpt
16
cardiovascular risk
16
patients
15
primary hyperparathyroidism
12
parameters patients
12
ncphpt
11
echocardiographic findings
8
patients normocalcemic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!